Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients.
Card Electrophysiol Clin
; 14(1): 11-20, 2022 03.
Статья
в английский
| MEDLINE | ID: covidwho-1487624
ABSTRACT
We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
COVID-19
Тип исследования:
Наблюдательное исследование
/
Прогностическое исследование
Пределы темы:
Люди
Язык:
английский
Журнал:
Card Electrophysiol Clin
Год:
2022
Тип:
Статья
Аффилированная страна:
J.ccep.2021.10.002
Документы, близкие по теме
MEDLINE
...
LILACS
LIS